Edwards Lifesciences (EW) is a publicly traded Healthcare sector company. As of October 11, 2026, EW trades at $85.21 with a market cap of $49.12B and a P/E ratio of 50.16. EW moved +1.15% today. Year to date, EW is -0.14%; over the trailing twelve months it is +13.33%. Its 52-week range spans $65.94 to $96.29. Analyst consensus is strong buy with an average price target of $103.40. Rallies surfaces EW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EW financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EW recently traded at $85.21. Market cap is $49.12B. P/E ratio is 50.16. Revenue is $6.51B.
| Metric | Value |
|---|---|
| Price | $85.21 |
| Market Cap | $49.12B |
| P/E Ratio | 50.16 |
| EPS | $1.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $96.29 |
| 52-Week Low | $65.94 |
| Volume | 3.18M |
| Avg Volume | 0 |
| Revenue (TTM) | $6.51B |
| Net Income | $1.00B |
| Gross Margin | 77.84% |
17 analysts cover EW: 0 strong buy, 14 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $103.40.